XTX Topco’s Inozyme Pharma INZY Stock Holding History

XTX Topco’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-70,171	Closed	-$281K	–	2885
2025 Q2	$281K	Sell	70,171 -40,514	-37%	-$100K	0.01%	1479
2025 Q1	$101K	Buy	110,685 +78,948	+249%	+$109K	0.01%	1867
2024 Q4	$87.9K	Buy	+31,737	New	+$121K	0.01%	1793
2024 Q1	–	Sell	-29,489	Closed	-$126K	–	2069
2023 Q4	$126K	Buy	+29,489	New	+$105K	0.03%	1081

XTX Topco's INZY Position: Q3 2025 in Review

XTX Topco sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 70,171 shares — an estimated $281K sold.

XTX Topco first reported a position in INZY in Q4 2023 and held it in 4 quarters. The position peaked at $281K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

XTX Topco reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
XTX Topco sold 70,171 Inozyme Pharma shares in Q3 2025, an estimated $281K.
XTX Topco first reported a position in Inozyme Pharma in Q4 2023 and held it in 4 quarters.
XTX Topco's Inozyme Pharma position peaked at $281K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.